Last reviewed · How we verify

NCT03842657: C2D

Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate

Completed Phase 2 Last updated 15 December 2025
What this trial tests

Phase 2 trial testing anticoagulation of the dialysis circuit in Hemodialysis Complication in 97 participants. Completed in 13 September 2021.

Timeline
5 July 2019
Primary endpoint
13 September 2021
13 September 2021

Quick facts

Lead sponsorUniversity Hospital, Toulouse
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment97
Start date5 July 2019
Primary completion13 September 2021
Estimated completion13 September 2021
Sites5 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Hemodialysis Complication or Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Critically ill patients have a high risk of bleeding but also require prolonged intermittent dialysis. Thus, a heparin-free easy-to-use alternative type of anticoagulation within the dialysis circuit is required. In a non-comparative study, heparin-free regional citrate anticoagulation of the dialysis circuit using a calcium-free citrate-containing dialysate, with calcium reinjected according to ionic dialysance, was considered as safe and efficient. The aim of this study is to confirm the superiority of this approach compared to a anticoagulation based on heparin-grafted membrane.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis.
    Faguer S, Serre JE, Brusq C, Bongard V, et al · · 2025 · cited 1× · PMID 38977911 · DOI 10.1093/ndt/gfae155

Verify or expand the search:

Other recruiting trials for Hemodialysis Complication

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03842657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing